$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Fate Therapeutics, Inc.
Operates as a clinical stage biopharmaceutical company
Sector
Health Technology
CEO
J. Scott Wolchko
Industry
Biotechnology
Exchange
NAS
Website
Top Stories
Coming soon.